Michael Cato

Cato Research LLC operates as an international regulatory and clinical contract research organization. It offers clinical strategy, clinical trial services, data management and biostatistics, medical and pharmacovigilance, medical writing, pharmacokinetics, preclinical/nonclinical services, project management, quality assurance, and regulatory affairs. The company was founded by Allen Cato and Lynda Sutton in 1988 and is headquartered in Durham, NC.

Hemodynamic Therapeutics, Inc. develops a novel small molecule combination therapy for obesity-related hypertension. The firm is developing its novel small molecule combination therapy (HTI-101) for obesity-related hypertension, one of the world's fastest growing cardiovascular disease markets. It has recently completed an initial Phase 2 clinical trial of HTI-101 in obese individuals with mild to moderate treatment-resistant hypertension. The company was founded in 2004 and is headquartered in Raleigh, NC.

Cato BioVentures (Cato BioVentures) is a venture capital subsidiary of Cato Research LLC founded in 1990 by Allen Cato and Lynda Sutton. The firm is headquartered in Durham, North Carolina.